IE000S9YS762 - Common Stock

Taking everything into account, **LIN** scores **5** out of 10 in our fundamental rating. **LIN** was compared to 84 industry peers in the **Chemicals** industry. While **LIN** has a great profitability rating, there are some minor concerns on its financial health. **LIN** is quite expensive at the moment. It does show a decent growth rate.

Of the past 5 years **LIN** 4 years had a positive operating cash flow.

The **Return On Assets** of **LIN** (**7.98%**) is better than **89.29%** of its industry peers.

Looking at the **Return On Equity**, with a value of **16.76%**, **LIN** belongs to the top of the industry, outperforming **83.33%** of the companies in the same industry.

Measured over the past 3 years, the **Average Return On Invested Capital** for **LIN** is in line with the industry average of **6.35%**.

The last **Return On Invested Capital** (**9.04%**) for **LIN** is above the 3 year average (**7.28%**), which is a sign of increasing profitability.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.98% | ||

ROE | 16.76% | ||

ROIC | 9.04% |

ROA(3y)5.86%

ROA(5y)4.61%

ROE(3y)11.55%

ROE(5y)8.92%

ROIC(3y)7.28%

ROIC(5y)5.78%

In the last couple of years the **Profit Margin** of **LIN** has declined.

The **Operating Margin** of **LIN** (**25.47%**) is better than **92.86%** of its industry peers.

In the last couple of years the **Operating Margin** of **LIN** has grown nicely.

In the last couple of years the **Gross Margin** of **LIN** has grown nicely.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | 25.47% | ||

PM (TTM) | 19.49% | ||

GM | 47.56% |

OM growth 3Y19.64%

OM growth 5Y10.21%

PM growth 3Y27.14%

PM growth 5Y-8.57%

GM growth 3Y2.41%

GM growth 5Y3.59%

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so **LIN** is still creating some value.

There is no outstanding debt for **LIN**. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

An Altman-Z score of **4.14** indicates that **LIN** is not in any danger for bankruptcy at the moment.

Looking at the **Altman-Z score**, with a value of **4.14**, **LIN** belongs to the top of the industry, outperforming **88.10%** of the companies in the same industry.

The Debt to FCF ratio of **LIN** is **4.44**, which is a neutral value as it means it would take **LIN**, **4.44** years of fcf income to pay off all of its debts.

With a **Debt to Equity ratio** value of **0.53**, **LIN** perfoms like the industry average, outperforming **58.33%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.53 | ||

Debt/FCF | 4.44 | ||

Altman-Z | 4.14 |

ROIC/WACC1.09

WACC8.27%

Looking at the **Current ratio**, with a value of **0.95**, **LIN** is doing worse than **92.86%** of the companies in the same industry.

The **Quick ratio** of **LIN** (**0.80**) is worse than **85.71%** of its industry peers.

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 0.95 | ||

Quick Ratio | 0.8 |

The **Earnings Per Share** has grown by an nice **11.85%** over the past year.

The **Earnings Per Share** has been growing by **16.48%** on average over the past years. This is quite good.

The **Revenue** has been growing by **17.23%** on average over the past years. This is quite good.

EPS 1Y (TTM)11.85%

EPS 3Y19.27%

EPS 5Y16.48%

EPS Q2Q%7.84%

Revenue 1Y (TTM)-0.81%

Revenue growth 3Y6.44%

Revenue growth 5Y17.23%

Sales Q2Q%0.77%

The **Revenue** is expected to grow by **4.21%** on average over the next years.

EPS Next Y6.52%

EPS Next 2Y11.2%

EPS Next 3Y10.86%

EPS Next 5Y9.9%

Revenue Next Year5.62%

Revenue Next 2Y1.14%

Revenue Next 3Y2.65%

Revenue Next 5Y4.21%

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

With a **Price/Earnings** ratio of **31.63**, **LIN** can be considered very expensive at the moment.

When comparing the **Price/Earnings** ratio of **LIN** to the average of the S&P500 Index (**30.52**), we can say **LIN** is valued inline with the index average.

The **Price/Forward Earnings** ratio is **27.12**, which means the current valuation is very expensive for **LIN**.

Based on the **Price/Forward Earnings** ratio, **LIN** is valued a bit more expensive than 70.24% of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 31.63 | ||

Fwd PE | 27.12 |

Based on the **Enterprise Value to EBITDA** ratio, **LIN** is valued a bit more expensive than 72.62% of the companies in the same industry.

Based on the **Price/Free Cash Flow** ratio, **LIN** is valued a bit more expensive than the industry average as 61.90% of the companies are valued more cheaply.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 46.47 | ||

EV/EBITDA | 19.57 |

The high **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.

PEG (NY)4.85

PEG (5Y)1.92

EPS Next 2Y11.2%

EPS Next 3Y10.86%

Compared to an average S&P500 **Dividend Yield** of **2.26**, **LIN**'s dividend is way lower than the S&P500 average.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.19% |

On average, the dividend of **LIN** grows each year by **12.74%**, which is quite nice.

Dividend Growth(5Y)12.74%

Div Incr Years31

Div Non Decr Years31

The dividend of **LIN** is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.

DP40.17%

EPS Next 2Y11.2%

EPS Next 3Y10.86%

**LINDE PLC**

NASDAQ:LIN (9/13/2024, 8:26:52 PM)

After market: 468.81 0 (0%)**468.81**

**+1.47 (+0.31%) **

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap225.37B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 1.19% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | 31.63 | ||

Fwd PE | 27.12 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)4.85

PEG (5Y)1.92

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | 7.98% | ||

ROE | 16.76% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | 25.47% | ||

PM (TTM) | 19.49% | ||

GM | 47.56% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.41

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 0.53 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 0.95 | ||

Quick Ratio | 0.8 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)11.85%

EPS 3Y19.27%

EPS 5Y

EPS Q2Q%

EPS Next Y6.52%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-0.81%

Revenue growth 3Y6.44%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y